IP Library Granted Patent US 9,408,899
Granted Patent B2
US 9,408,899 · App. 13/823,668 · Granted Aug 9, 2016

Vaccines against

Inventors: Rima McLeod (Chicago, IL); Tze Guan Tan (Cambridge, MA); Jeffery L. Alexander (San Diego, CA); Hua Cong (Shandong, CN); William H. Witola (Auburn, AL); Kamal El Bissati (Chicago, IL); Ernest J. Mui (Chicago, IL); Steven G. Reed (Bellevue, WA)
Assignees: The University of Chicago; Infectious Disease Research Institute; Paxvax, Inc.
A61K39/002A61K2039/55572A61K2039/6031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,408,899
App. No.
13/823,668
Granted
Aug 9, 2016
Kind
B2
Abstract

Vaccines are disclosed against parasites. The vaccines include peptides in an immunological composition. In particular, the parasite is Toxoplas gondii.

Claims (9)

1. A composition comprising a plurality of peptides, wherein the plurality of peptides comprises a first peptide with the amino acid sequence KSFKDILPK (SEQ ID NO: 4), a second peptide with the amino acid sequence RSFKDLLKK (SEQ ID NO: 6), and a third peptide with the amino acid sequence AKFVAAWTLKAAA (SEQ ID NO: 7), wherein the plurality of peptides are linked to form a chimeric polypeptide.

2. The composition of claim 1 , wherein the composition comprises an oil-in-water emulsion that includes a synthetic adjuvant monophosphorvl lipid A (MLA).

3. The composition of claim 1 wherein the plurality of peptides further comprises one or more of AVVSLLRLLK (SEQ ID NO:23), STFWPCLLR (SEQ ID NO:21), and SSAYVFSVK (SEQ ID NO:22).

4. The composition of claim 3 , further comprising an adjuvant.

5. The composition of claim 3 wherein the plurality of peptides further comprises one or more of FLSLSLLVI (SEQ ID NO: 11) FMIAFISCFA (SEQ ID NO: 12), FVIFACNFV (SEQ ID NO: 16), FMIVSISLY (SEQ ID NO: 13), FLLGLLVHV (SEQ ID NO: 15), FLTDYIPGA (SEQ ID NO: 14), ITMGSLFFV (SEQ ID NO: 17), GLAAAVYAV (SEQ ID NO: 18), VLLPVLFGV (SEQ ID NO: 20), FAAAFFPAV (SEQ ID NO: 19), VVFVVFMGV (SEQ ID NO: 1), FMGVLVNSL (SEQ ID NO: 2), FLVPFVVFL (SEQ ID NO: 3), AMLTAFFLR (SEQ ID NO: 5), LPOFATAAT (SEQ ID NO: 8), VPFVVFLVA (SEQ ID NO: 9), and HF10 (HPGSVNEFDF (SEQ ID NO: 10)).

6. The composition of claim 5 , further comprising an adjuvant.

7. The composition of claim 1 wherein the plurality of peptides further comprises one or more of FLSLSLLVI (SEQ ID NO: 11), FMIAFISCFA (SEQ ID NO: 12), FVIFACNFV (SEQ ID NO: 16), FMIVSISLV (SEQ ID NO: 13), FLLGLLVHV (SEQ ID NO: 15), FLTDYIPGA (SEQ ID NO: 14), ITMGSLFFV (SEQ ID NO: 17), GLAAAVVAV (SEQ ID NO: 18), VLLPVLFGV (SEQ ID NO: 20), FAAAFFPAV (SEQ ID NO: 19), VVFVVFMGV (SEQ ID NO: 1), FMGVLVNSL (SEQ ID NO: 2), FLVPFVVFL (SEQ ID NO: 3), AMLTAFFLR (SEQ ID NO: 5), LPQFATAAT (SEQ ID NO: 8), VPFVVFLVA (SEQ ID NO: 9), and HF10 (HPGSVNEFDF (SEQ ID NO: 10)).

8. The composition of claim 7 , further comprising an adjuvant.

9. The composition of claim 1 further comprising an adjuvant.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 29, 2026
From: OHA AGENCY LLC, IN ITS CAPACITY AS ADMINISTRATIVE AGENT
To: EMERGENT TRAVEL HEALTH INC.
Reel/Frame 074509/0667 →
SECURITY INTEREST Recorded Sep 30, 2024
From: EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT BIOSOLUTIONS INC.; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC; EMERGENT TRAVEL HEALTH INC.; EMERGENT BIOSOLUTIONS CANADA INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 068746/0698 →
NOTICE OF GRANT OF SECURITY INTEREST IN U.S. PATENTS Recorded Sep 3, 2024
From: EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT BIOSOLUTIONS CANADA INC.; EMERGENT BIOSOLUTIONS INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.; EMERGENT TRAVEL HEALTH INC.
To: OHA AGENCY LLC
Reel/Frame 068828/0233 →
CHANGE OF NAME Recorded Aug 6, 2019
From: PAX VAX INX
To: EMERGENT TRAVEL HEALTH INC.
Reel/Frame 049968/0671 →
CONFIRMATORY LICENSE Recorded Sep 23, 2015
From: UNIVERSITY OF CHICAGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036664/0897 →
Continuity (2)
Provisional Application 61456309 · Nov 4, 2010
Related Publication 20130273094A1 · Oct 17, 2013